🇯🇵·6d agoResearch
デュルバルマブ（遺伝子組換え）製剤の最適使用推進ガイドライン（胃癌）の作成及び最適使用推進ガイドライン（非小細胞肺癌、小細胞肺癌、肝細胞癌、胆道癌、子宮体癌及び膀胱癌）の一部改正について（厚生労働省）
Publisher
J
Japanese Society of Medical Oncology
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Japanese Society of Medical Oncology
- Region
- Japan
- Scope
- Research
- Published
- June 24, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on jsmo.or.jp
Leave the platform to read the original full article on the publisher site.
Source: Japanese Society of Medical Oncology
Scope: Research
Related coverage
More related coverage
UNLP Health Sciences/47m ago
Artrosis canina: desarrollan un tratamiento a base de cartílago de tiburón
Cancer Research UK/1h ago
Is there a link between faster ageing and early-onset cancer risk?
Atlas Venture/1h ago
Two Roads Diverged
University of Edinburgh/2h ago